The consistent upregulation of ARL2 in the blood of patients with stroke, sleep disorder, and most notably in those with both conditions, strongly corroborates our pre-clinical findings and underscores the translational relevance of ARL2 as a peripheral biomarker. This evidence concerns the gene ARL2 and Stroke.